Screening for hepatoblastoma by liver palpation, abdominal ultrasound, and serum alpha-fetoprotein every 3–6 months until the age of 5 years [9] or every 2 years until the age of 7 years [220] has been proposed. This evidence concerns the gene AFP and hepatoblastoma.